Company Dynamics - The company, Yidu Tech, has been advancing its AI medical business, launching upgraded core products such as AI Middle Platform 2.0, and has successfully implemented these solutions in leading hospitals [1] - The company reported a significant reduction in losses for the fiscal year 2025, indicating a potential for steady revenue growth supported by the recovery of industry demand and a focused AI strategy [1] Financial Performance - For the fiscal year 2025, Yidu Tech recorded revenue of 710 million yuan, a year-on-year decrease of 11.4%. The big data platform and solutions business saw a revenue increase of 10.3% to 350 million yuan, while life sciences solutions revenue decreased by 23.7% to 250 million yuan [2] - The company’s net loss attributable to shareholders was 120 million yuan, a significant reduction from the previous year's loss of 190 million yuan, primarily due to ongoing cost reduction and efficiency improvements [2] Future Outlook - The company maintains its revenue and net profit forecasts for fiscal year 2026 and introduces a forecast for fiscal year 2027, expecting revenue of 870 million yuan and a net profit of 4.11 million yuan [2] - The target price has been raised by 36% to 6.8 HKD, reflecting the company's progress in new business areas such as the AI Middle Platform, with a projected upside of 16% from the current stock price [2]